Abstract
Patients who receive transcatheter aortic valve replacement are at risk for leaflet thrombosis-related complications, and can benefit from continuous, longitudinal monitoring of the prosthesis. Conventional angiography modalities are expensive, hospital-centric and either invasive or employ potentially nephrotoxic contrast agents, which preclude their routine use. Heart sounds have been long recognized to contain valuable information about individual valve function, but the skill of auscultation is in decline due to its heavy reliance on the physician’s proficiency leading to poor diagnostic repeatability. This subjectivity in diagnosis can be alleviated using machine learning techniques for anomaly detection. We present a computational and data-driven proof-of-concept analysis of a novel, auscultation-based technique for monitoring aortic valve, which is practical, non-invasive, and non-toxic. However, the underlying mechanisms leading to physiological and pathological heart sounds are not well-understood, which hinders development of such a technique. We first address this by performing direct numerical simulations of the complex interactions between turbulent blood flow in a canonical ascending aorta model and dynamic valve motion in 29 cases with healthy and stenotic valves. Using the turbulent pressure fluctuations on the aorta lumen boundary, we model the propagation of heart sounds, as elastic waves, through the patient’s thorax. The heart sound may be recorded on the epidermal surface using a stethoscope/phonocardiograph. This approach allows us to correlate instantaneous hemodynamic phenomena and valve motion with the acoustic response. From this dataset we extract “acoustic signatures” of healthy and stenotic valves based on principal components of the recorded sound. These signatures are used to train a linear discriminant classifier by maximizing correlation between recorded heart sounds and valve status. We demonstrate that this classifier is capable of accurate prospective detection of anomalous valve function and that the principal component-based signatures capture prominent audible features of heart sounds, which have been historically used by physicians for diagnosis. Further development of such technology can enable inexpensive, safe and patient-centric at-home monitoring, and can extend beyond transcatheter valves to surgical as well as native valves.
Highlights
Heart diseases are the leading cause of death in the United States, with more than 600,000 associated annual deaths (Kung et al, 2008)
We provide the first of its kind description of physiologically realistic fluid-structure interaction (FSI) inside the ascending aorta with healthy and stenotic TAVs and the consequent sound generation and propagation in the surrounding tissue-like material
Aortic stenosis is induced by increasing the stiffness parameter κ in one or more valve leaflet over its baseline value such that area stenosis is at most mild
Summary
Heart diseases are the leading cause of death in the United States, with more than 600,000 associated annual deaths (Kung et al, 2008). The gold standard of aortic valve replacement has been surgical replacement (SAVR), but it is limited to patients who can handle the trauma of an open-heart surgery. In the last two decades, transcatheter aortic valve replacement (TAVR) has emerged as a viable AVR modality, especially for frail and high-risk patients. Due to comparable patient outcomes and a significant reduction in periprocedural trauma, TAVR has recently been expanded to include moderateand low-risk patients. The bioprosthetic valves (BPV) employed in TAVR are made of tissue grafted from porcine or bovine pericardium, which are less thrombogenic and have overall better hemodynamic characteristics, compared to mechanical valves, even in low- and moderate-risk patients with severe AS (Reardon et al, 2017; Kolte et al, 2019)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.